ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 13, No. 11, November 2026 | pp. 812–819
DOI: 10.46882/AJIDR/149019
Article Type: Research Article
Title: Clinical outcomes and linezolid susceptibility of Nocardia species causing pulmonary and disseminated nocardiosis in immunocompromised hosts
Names of Authors: Henrik Lindberg¹*, Fatima Bello², Arjun Nair³
Abstract: Nocardiosis is an opportunistic granulomatous bacterial infection affecting patients with cell-mediated immunodeficiency, structural lung disease, or chronic corticosteroid use. We determined species distribution via 16S ribosomal RNA sequencing and antimicrobial susceptibility profiles among invasive nocardiosis cases. Respiratory and tissue specimens from 62 patients were cultured and tested via broth microdilution. Nocardia farcinica and Nocardia cyriacigeorgica accounted for 61.3 percent of isolates, with linezolid and trimethoprim-sulfamethoxazole demonstrating 100.0 percent and 91.9 percent susceptibility respectively. Early species identification guides prolonged combination antimicrobial regimens.
Keywords: Nocardia farcinica, Pulmonary nocardiosis, Opportunistic infections, Linezolid susceptibility, 16S rRNA sequencing
Citation: Lindberg H, Bello F, Nair A (2026). Clinical outcomes and linezolid susceptibility of Nocardia species causing pulmonary and disseminated nocardiosis in immunocompromised hosts. African Journal of Infectious Diseases Research, 13(11): 812–819. DOI: 10.46882/AJIDR/149019
Manuscript Timeline: Received: September 18, 2026; Revised: October 19, 2026; Accepted: November 12, 2026; Published: November 19, 2026
Subscribe to read the full article: https://mail.internationalscholarsjournals.org/subscribe-to-read